FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease

Detalhes bibliográficos
Autor(a) principal: Inoue, Cláudia Junko
Data de Publicação: 2022
Outros Autores: Flauzino, Tamires, Gonçalves, Beatriz Piantoni, Paula, Jaqueline Costa Castardo de, Galvão, Talita Cristina, Miyazaki, Paula Kikuchi, Alcantara, Camila Cataldi de, Westmore, Lucilene Rosa e Silva, Lozovoy, Marcell Alysson Batisti, Reiche, Edna Maria Vissoci, Simão, Andréa Name Colado
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/213522
Resumo: Objective: The aim of this study was to evaluate the association of -924 G>A (rs2232365) and -3279 C>A (rs3761548) FOXP3 variants with IBD susceptibility, clinical and endoscopic activity, and IL-10 and TGF-β1 plasma levels. Method: The study included 110 IBD female patients, 60 with Ulcerative Colitis (UC) and 50 with Crohn's Disease (CD), and 154 female controls. FOXP3 variants were determined with Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP). Plasma levels of IL-10 and TGF-β1 were determined using immunofluorimetric assay. Results: AA genotype of rs2232365 and rs3761548 was associated with CD (OR = 3.147, 95% CI 1.015–9.758, p = 0.047) and UC (OR = 3.221, 95% CI 1.050–9.876, p = 0.041) susceptibility, respectively. However, were not associated with TGF-β1 and IL-10 levels, and endoscopic/clinical activity disease. GAGA haplotype was associated with IBD (OR = 4.003, 95% CI 1.100–14.56, p = 0.035) and UC susceptibility (OR = 6.107, 95% CI 1.609–23.18, p = 0.008). In addition, IBD patients with the GAGA haplotype had lower TGF-β1 levels (p = 0.041). Moreover, G/C haplotype (dominant model) had a protective effect of 60% in CD susceptibility and lower Endoscopic Severity Index. Conclusions: These results suggest that FOXP3 variants could exert a role in the Treg, which could be one of the factors involved in the susceptibility and pathogenesis of IBD.
id USP-19_dc0cc63735bf1617f316d40a90b62d9c
oai_identifier_str oai:revistas.usp.br:article/213522
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel diseaseInflammatory bowel diseasesUlcerative colitisrohn's diseaseForkhead box protein 3 genetic variantsTransforming growth Factor β1Objective: The aim of this study was to evaluate the association of -924 G>A (rs2232365) and -3279 C>A (rs3761548) FOXP3 variants with IBD susceptibility, clinical and endoscopic activity, and IL-10 and TGF-β1 plasma levels. Method: The study included 110 IBD female patients, 60 with Ulcerative Colitis (UC) and 50 with Crohn's Disease (CD), and 154 female controls. FOXP3 variants were determined with Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP). Plasma levels of IL-10 and TGF-β1 were determined using immunofluorimetric assay. Results: AA genotype of rs2232365 and rs3761548 was associated with CD (OR = 3.147, 95% CI 1.015–9.758, p = 0.047) and UC (OR = 3.221, 95% CI 1.050–9.876, p = 0.041) susceptibility, respectively. However, were not associated with TGF-β1 and IL-10 levels, and endoscopic/clinical activity disease. GAGA haplotype was associated with IBD (OR = 4.003, 95% CI 1.100–14.56, p = 0.035) and UC susceptibility (OR = 6.107, 95% CI 1.609–23.18, p = 0.008). In addition, IBD patients with the GAGA haplotype had lower TGF-β1 levels (p = 0.041). Moreover, G/C haplotype (dominant model) had a protective effect of 60% in CD susceptibility and lower Endoscopic Severity Index. Conclusions: These results suggest that FOXP3 variants could exert a role in the Treg, which could be one of the factors involved in the susceptibility and pathogenesis of IBD.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2022-07-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/21352210.1016/j.clinsp.2022.100084Clinics; Vol. 77 (2022); 100084Clinics; v. 77 (2022); 100084Clinics; Vol. 77 (2022); 1000841980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/213522/195618Copyright (c) 2023 Clinicsinfo:eu-repo/semantics/openAccessInoue, Cláudia JunkoFlauzino, TamiresGonçalves, Beatriz PiantoniPaula, Jaqueline Costa Castardo deGalvão, Talita CristinaMiyazaki, Paula KikuchiAlcantara, Camila Cataldi deWestmore, Lucilene Rosa e SilvaLozovoy, Marcell Alysson BatistiReiche, Edna Maria VissociSimão, Andréa Name Colado2023-07-06T13:04:57Zoai:revistas.usp.br:article/213522Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2023-07-06T13:04:57Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease
title FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease
spellingShingle FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease
Inoue, Cláudia Junko
Inflammatory bowel diseases
Ulcerative colitis
rohn's disease
Forkhead box protein 3 genetic variants
Transforming growth Factor β1
title_short FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease
title_full FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease
title_fullStr FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease
title_full_unstemmed FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease
title_sort FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease
author Inoue, Cláudia Junko
author_facet Inoue, Cláudia Junko
Flauzino, Tamires
Gonçalves, Beatriz Piantoni
Paula, Jaqueline Costa Castardo de
Galvão, Talita Cristina
Miyazaki, Paula Kikuchi
Alcantara, Camila Cataldi de
Westmore, Lucilene Rosa e Silva
Lozovoy, Marcell Alysson Batisti
Reiche, Edna Maria Vissoci
Simão, Andréa Name Colado
author_role author
author2 Flauzino, Tamires
Gonçalves, Beatriz Piantoni
Paula, Jaqueline Costa Castardo de
Galvão, Talita Cristina
Miyazaki, Paula Kikuchi
Alcantara, Camila Cataldi de
Westmore, Lucilene Rosa e Silva
Lozovoy, Marcell Alysson Batisti
Reiche, Edna Maria Vissoci
Simão, Andréa Name Colado
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Inoue, Cláudia Junko
Flauzino, Tamires
Gonçalves, Beatriz Piantoni
Paula, Jaqueline Costa Castardo de
Galvão, Talita Cristina
Miyazaki, Paula Kikuchi
Alcantara, Camila Cataldi de
Westmore, Lucilene Rosa e Silva
Lozovoy, Marcell Alysson Batisti
Reiche, Edna Maria Vissoci
Simão, Andréa Name Colado
dc.subject.por.fl_str_mv Inflammatory bowel diseases
Ulcerative colitis
rohn's disease
Forkhead box protein 3 genetic variants
Transforming growth Factor β1
topic Inflammatory bowel diseases
Ulcerative colitis
rohn's disease
Forkhead box protein 3 genetic variants
Transforming growth Factor β1
description Objective: The aim of this study was to evaluate the association of -924 G>A (rs2232365) and -3279 C>A (rs3761548) FOXP3 variants with IBD susceptibility, clinical and endoscopic activity, and IL-10 and TGF-β1 plasma levels. Method: The study included 110 IBD female patients, 60 with Ulcerative Colitis (UC) and 50 with Crohn's Disease (CD), and 154 female controls. FOXP3 variants were determined with Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP). Plasma levels of IL-10 and TGF-β1 were determined using immunofluorimetric assay. Results: AA genotype of rs2232365 and rs3761548 was associated with CD (OR = 3.147, 95% CI 1.015–9.758, p = 0.047) and UC (OR = 3.221, 95% CI 1.050–9.876, p = 0.041) susceptibility, respectively. However, were not associated with TGF-β1 and IL-10 levels, and endoscopic/clinical activity disease. GAGA haplotype was associated with IBD (OR = 4.003, 95% CI 1.100–14.56, p = 0.035) and UC susceptibility (OR = 6.107, 95% CI 1.609–23.18, p = 0.008). In addition, IBD patients with the GAGA haplotype had lower TGF-β1 levels (p = 0.041). Moreover, G/C haplotype (dominant model) had a protective effect of 60% in CD susceptibility and lower Endoscopic Severity Index. Conclusions: These results suggest that FOXP3 variants could exert a role in the Treg, which could be one of the factors involved in the susceptibility and pathogenesis of IBD.
publishDate 2022
dc.date.none.fl_str_mv 2022-07-27
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/213522
10.1016/j.clinsp.2022.100084
url https://www.revistas.usp.br/clinics/article/view/213522
identifier_str_mv 10.1016/j.clinsp.2022.100084
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/213522/195618
dc.rights.driver.fl_str_mv Copyright (c) 2023 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 77 (2022); 100084
Clinics; v. 77 (2022); 100084
Clinics; Vol. 77 (2022); 100084
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222766663729152